Page last updated: 2024-11-04

linsidomine and Pheochromocytoma

linsidomine has been researched along with Pheochromocytoma in 1 studies

linsidomine: RN given refers to parent cpd; structure

Pheochromocytoma: A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of EPINEPHRINE and NOREPINEPHRINE, is HYPERTENSION, which may be persistent or intermittent. During severe attacks, there may be HEADACHE; SWEATING, palpitation, apprehension, TREMOR; PALLOR or FLUSHING of the face, NAUSEA and VOMITING, pain in the CHEST and ABDOMEN, and paresthesias of the extremities. The incidence of malignancy is as low as 5% but the pathologic distinction between benign and malignant pheochromocytomas is not clear. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1298)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dötsch, J1
Hänze, J1
Dittrich, K1
Demirakça, S1
Haberberger, R1
Rascher, W1

Other Studies

1 other study available for linsidomine and Pheochromocytoma

ArticleYear
Stimulation of neuropeptide Y release in rat pheochromocytoma cells by nitric oxide.
    European journal of pharmacology, 1997, Jul-23, Volume: 331, Issue:2-3

    Topics: Animals; Blotting, Northern; Enzyme Inhibitors; Immunohistochemistry; Molsidomine; Nerve Growth Fact

1997